BM
Brandywine Managers Portfolio holdings
AUM
$101M
This Quarter Return
+23.04%
1 Year Return
+24.43%
3 Year Return
+74.73%
5 Year Return
+125.12%
10 Year Return
+356.43%
AUM
$101M
AUM Growth
+$101M
(+21%)
Cap. Flow
-$22.7K
Cap. Flow
% of AUM
-0.02%
Top 10 Holdings %
Top 10 Hldgs %
84.01%
Holding
36
New
1
Increased
3
Reduced
8
Closed
–
Top Buys
| 1 |
Viking Therapeutics
VKTX
|
$214K |
| 2 |
Klaviyo
KVYO
|
$146K |
| 3 |
MongoDB
MDB
|
$130K |
| 4 |
Beam Therapeutics
BEAM
|
$124K |
Top Sells
| 1 |
SentinelOne
S
|
$155K |
| 2 |
Veeva Systems
VEEV
|
$144K |
| 3 |
Advanced Micro Devices
AMD
|
$114K |
| 4 |
Okta
OKTA
|
$80K |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$42.4K |
Sector Composition
| 1 | Technology | 50.63% |
| 2 | Healthcare | 10.84% |
| 3 | Financials | 1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Schrodinger
SDGR
$1.44B
| $420K | 0.42% | 20,886 | – | – |
|
|
27
Beam Therapeutics
BEAM
$1.66B
| $316K | 0.31% | 18,606 +7,300 | +65% | +$124K |
|
28
Twilio
TWLO
$16.2B
| $293K | 0.29% | 2,357 | – | – |
|
29
Moderna
MRNA
$9.37B
| $262K | 0.26% | 9,510 | – | – |
|
30
Novo Nordisk
NVO
$251B
| $259K | 0.26% | 3,747 -475 | -11% | -$32.8K |
|
31
Structure Therapeutics
GPCR
$1.11B
| $229K | 0.23% | 11,057 | – | – |
|
32
10x Genomics
TXG
$1.74B
| $219K | 0.22% | 18,938 | – | – |
|
|
33
Viking Therapeutics
VKTX
$3.04B
| $214K | 0.21% | +8,082 | New | +$214K |
|
|
34
SentinelOne
S
$6.29B
| $192K | 0.19% | 10,501 -8,500 | -45% | -$155K |
|
35
Relay Therapeutics
RLAY
$619M
| $133K | 0.13% | 38,429 | – | – |
|
36
AbCellera Biologics
ABCL
$1.25B
| $97.7K | 0.1% | 28,488 | – | – |
|